Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC temporary/transient transmission failures. As we discussed previously in this final rule, we decided against imposing either of those alternatives in light of the advantage of the momentum that will be built by the e-prescribing incentive program under MIPPA, and affording the industry an additional 3 years from the effective date of this final rule to move toward true e-prescribing. J. CORF issues The revisions to the CORF regulations discussed in section II.L. of this final rule with comment period updates the regulations for consistency with the PFS payment rules and make additional changes to the conditions of participation to reflect industry standards. These revisions will help to clarify payment and operational requirements for CORF services and are expected to have minimal impact on Medicare expenditures. K. Therapy Issues The revisions to the therapy regulations discussed in section II.M. of this final rule with comment period make technical corrections and update the regulations and are expected to have minimal impact on Medicare expenditures. L. Physician Self-referral Provisions We anticipate that the provisions in section II.N. of this final rule with comment period concerning the 1068
CMS-1403-FC anti-markup provisions in §414.50 will result in savings to the program by reducing overutilization and anti-competitive business arrangements. We cannot gauge with any certainty the extent of these savings to the Medicare program. M1. Physician Quality Reporting Initiative (PQRI) As discussed section II.O1. of this final rule with comment period, the final 2009 PQRI measures satisfy the requirement of section 1848(k)(2)(B)(iii) of the Act that the Secretary publish in the Federal Register by November 15, 2008 a final set of quality measures that the Secretary determines would be appropriate for eligible professionals to use to submit data to the Secretary in 2009. As discussed in section II.O1. of this final rule with comment period, we are also offering options in 2009 for reporting some of the 2009 PQRI measures via submission of data to a clinical registry and options for reporting on measures groups rather than individual measures. Although there may be some cost incurred for maintaining the measures used in the PQRI and their associated code sets, and for expanding an existing clinical data warehouse to accommodate registry-based data submission for the PQRI, we do not anticipate a significant cost impact on the Medicare program. 1069
- Page 1017 and 1018: CMS-1403-FC to several associated i
- Page 1019 and 1020: CMS-1403-FC incentive payment for 2
- Page 1021 and 1022: CMS-1403-FC year of PQRI reporting)
- Page 1023 and 1024: CMS-1403-FC Based on the assumption
- Page 1025 and 1026: CMS-1403-FC these activities for th
- Page 1027 and 1028: CMS-1403-FC per hour, we estimate t
- Page 1029 and 1030: CMS-1403-FC Because of the large nu
- Page 1031 and 1032: CMS-1403-FC threshold, and hence al
- Page 1033 and 1034: CMS-1403-FC shoes, the regulation i
- Page 1035 and 1036: CMS-1403-FC with comment period for
- Page 1037 and 1038: CMS-1403-FC substance of State laws
- Page 1039 and 1040: CMS-1403-FC $20 million from what e
- Page 1041 and 1042: CMS-1403-FC ● Impact of Work RVU
- Page 1043 and 1044: CMS-1403-FC imaging services from t
- Page 1045 and 1046: CMS-1403-FC ● Impact of section 1
- Page 1047 and 1048: CMS-1403-FC management, could have
- Page 1049 and 1050: CMS-1403-FC Table 50 illustrates, f
- Page 1051 and 1052: CMS-1403-FC CPT/ HCPCS Mod Descript
- Page 1053 and 1054: CMS-1403-FC impact associated with
- Page 1055 and 1056: CMS-1403-FC The fourth column shows
- Page 1057 and 1058: CMS-1403-FC the CY 2007 claims. The
- Page 1059 and 1060: CMS-1403-FC 1059 4/This column show
- Page 1061 and 1062: CMS-1403-FC requirements is to allo
- Page 1063 and 1064: CMS-1403-FC This amendment of the e
- Page 1065 and 1066: CMS-1403-FC 4 minutes per call, lab
- Page 1067: CMS-1403-FC e-prescribing and who m
- Page 1071 and 1072: CMS-1403-FC approximately $50 per h
- Page 1073 and 1074: CMS-1403-FC e-prescribing measure i
- Page 1075 and 1076: CMS-1403-FC we estimate that each e
- Page 1077 and 1078: CMS-1403-FC P. Prohibition Concerni
- Page 1079 and 1080: CMS-1403-FC that provides a calcula
- Page 1081 and 1082: CMS-1403-FC treatment) that occur a
- Page 1083 and 1084: CMS-1403-FC locality (+5.37 percent
- Page 1085 and 1086: CMS-1403-FC additional rental payme
- Page 1087 and 1088: CMS-1403-FC T. Competitive Acquisit
- Page 1089 and 1090: CMS-1403-FC Program; II.T. Electron
- Page 1091 and 1092: CMS-1403-FC which means that in 200
- Page 1093 and 1094: CMS-1403-FC List of Subjects 42 CFR
- Page 1095 and 1096: CMS-1403-FC For the reasons set for
- Page 1097 and 1098: CMS-1403-FC (1) Except as specified
- Page 1099 and 1100: CMS-1403-FC pressure, a visual acui
- Page 1101 and 1102: CMS-1403-FC (ii) A speech-language
- Page 1103 and 1104: CMS-1403-FC during the hours that t
- Page 1105 and 1106: CMS-1403-FC (i) Be certified as a n
- Page 1107 and 1108: CMS-1403-FC 14. Section 410.155 is
- Page 1109 and 1110: CMS-1403-FC prostate cancer screeni
- Page 1111 and 1112: CMS-1403-FC B. Amending the definit
- Page 1113 and 1114: CMS-1403-FC The revisions and addit
- Page 1115 and 1116: CMS-1403-FC or institution other th
- Page 1117 and 1118: CMS-1403-FC substantially all (whic
<strong>CMS</strong>-1403-FC<br />
temporary/transient transmission failures. As we discussed<br />
previously in this final rule, we decided against imposing<br />
either of those alternatives in light of the advantage of<br />
the momentum that will be built by the e-prescribing<br />
incentive program under MIPPA, and affording the industry<br />
an additional 3 years from the effective date of this final<br />
rule to move toward true e-prescribing.<br />
J. CORF issues<br />
The revisions to the CORF regulations discussed in<br />
section II.L. of this final rule with comment period<br />
updates the regulations for consistency with the PFS<br />
payment rules and make additional changes to the conditions<br />
of participation to reflect industry standards. These<br />
revisions will help to clarify payment and operational<br />
requirements for CORF services and are expected to have<br />
minimal impact on Medicare expenditures.<br />
K. Therapy Issues<br />
The revisions to the therapy regulations discussed in<br />
section II.M. of this final rule with comment period make<br />
technical corrections and update the regulations and are<br />
expected to have minimal impact on Medicare expenditures.<br />
L. Physician Self-referral Provisions<br />
We anticipate that the provisions in section II.N. of<br />
this final rule with comment period concerning the<br />
1068